Ortho-McNeil-Janssen Articles

Valeant to acquire J&J’s Ortho Dermatologics for $345 million

18 July 2011

Another recall for J&J, as Ortho-McNeil reports odor problem with Risperdal

20 June 2011

Johnson & Johnson faces $327 million penalty over Risperdal marketing

6 June 2011

Watson shares jump as firm signs deal with Johnson & Johnson for authorized ADHD drug Concerta generic

3 November 2010

Anchor Thera to sell rights to cancer, metabolic disease drug candidates to Johnson & Johnson unit for $480 million

10 September 2010

J&J’s Ortho-McNeil unit in another diabetes drug accord, this one with Metabolex

23 June 2010

J&J’s Ortho-McNeil unit buys rights to Diamyd diabetes therapy for up to $625 million

22 June 2010

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end